SLCO1B1 and myopathy: Also, SLCO1B1*15 showed over 70% reduction in the transport activity compared with wild type and showed the association with myopathy in patients taking pravastatin and atorvastatin (Ghatak et al., 2010; Sirtori et al., 2012; Gong and Kim, 2013; Shitara et al., 2013; Maeda, 2015).